Core Insights - The Social Security Fund has disclosed its stock holdings for the third quarter, appearing in the top ten shareholders of 20 stocks on the Sci-Tech Innovation Board, with a total holding of 68.30 million shares valued at 4.24 billion yuan [1][2] Group 1: Stock Holdings - The Social Security Fund has newly entered 9 stocks, increased holdings in 4 stocks, reduced holdings in 5 stocks, and maintained its position in 2 stocks [1] - The stocks with the highest holdings by the Social Security Fund include Yingxiao Network (7.93 million shares), Sanyou Medical (7.91 million shares), and Nanwei Medical (6.27 million shares) [2][3] - The stock with the highest holding ratio is Haitai New Light at 4.20%, followed by Nanwei Medical at 3.34% [2] Group 2: Financial Performance - Among the stocks held by the Social Security Fund, 15 companies reported a year-on-year increase in net profit for the first three quarters, with Sanyou Medical showing the highest growth rate of 623.19% [2] - Other notable companies with significant net profit growth include Shengong Co. and New Xiangwei, with increases of 158.93% and 138.88%, respectively [2] Group 3: Market Performance - The average performance of the Sci-Tech Innovation Board stocks held by the Social Security Fund has seen a decline of 3.32% since October [3] - The best-performing stock is Puyuan Precision Electronics, with a cumulative increase of 6.18%, while Lexin Technology has experienced the largest decline at 13.80% [3]

Core Insights - The social security fund has disclosed its stock holdings for the third quarter, appearing in the top ten circulating shareholders of 20 stocks, with 9 new entries and 4 increases in holdings [1][2] Group 1: Stock Holdings - The total number of shares held by the social security fund in the 20 stocks is 68.2952 million, with a total market value of 4.237 billion yuan [1] - New entries include Sanyou Medical, Dongwei Technology, and Lexin Technology, with significant holdings [1] - The stocks with the highest number of social security fund shareholders include Yingxi Network, Nanwei Medical, Zhongwang Software, and Zhuoyi Information, with holdings of 7.934 million, 6.269 million, 3.809 million, and 2.337 million shares respectively [1] Group 2: Shareholding Ratios - The stock with the highest shareholding ratio by the social security fund is Haitai Xinguang, at 4.20%, followed by Nanwei Medical at 3.34% [2] - The largest number of shares held is in Yingxi Network, with 7.934 million shares, followed closely by Sanyou Medical and Nanwei Medical with 7.9145 million and 6.2692 million shares respectively [2] - The stocks with the highest market value held by the social security fund include Nanwei Medical, Lexin Technology, and Bochu Electronics, valued at 629 million, 598 million, and 542 million yuan respectively [2] Group 3: Performance Metrics - Among the stocks held by the social security fund, 15 reported year-on-year net profit growth in the first three quarters, with Sanyou Medical showing the highest increase of 623.19% [2] - Other notable net profit growth includes Shen Gong Co. and Xinxiang Micro, with increases of 158.93% and 138.88% respectively [2] - The social security fund's holdings are primarily concentrated in the electronics, computer, and power equipment industries, with 5, 4, and 3 stocks respectively [2] Group 4: Market Performance - The average decline of the stocks held by the social security fund since October is 3.32% [3] - The best-performing stock is Puyuan Precision, with a cumulative increase of 6.18%, followed by Maide Medical and Yingshi Innovation with increases of 4.89% and 4.22% respectively [3] - The stock with the largest decline is Lexin Technology, which has dropped by 13.80% [3]

Core Insights - Pension accounts have appeared in the top ten circulating shareholder lists of HaiTai New Light, DingTong Technology, Rejing Biology, and KaiYin Technology by the end of the third quarter [1] Group 1: Pension Holdings - The Basic Pension Insurance Fund 802 Combination is the fourth largest circulating shareholder of HaiTai New Light, holding 5.0346 million shares, accounting for 4.20% of circulating shares [1] - The Basic Pension Insurance Fund 1906 Combination and 16052 Combination are the seventh and ninth largest shareholders of DingTong Technology, with a total holding of 1.5174 million shares, representing 1.09% of circulating shares [1] - The Basic Pension Insurance Fund 16022 Combination is the ninth largest shareholder of Rejing Biology, holding 1.5001 million shares, which is 1.62% of circulating shares [1] - The Basic Pension Insurance Fund 2009 Combination is the eighth largest shareholder of KaiYin Technology, with a holding of 872.6 thousand shares, accounting for 0.51% of circulating shares [1] Group 2: Market Value of Holdings - The market value of HaiTai New Light's pension holdings is approximately 250.22 million [1] - The market value of DingTong Technology's pension holdings is approximately 144.02 million [1] - The market value of Rejing Biology's pension holdings is approximately 254.90 million [1] - The market value of KaiYin Technology's pension holdings is approximately 2.44 million [1]

证券代码：688677 证券简称：海泰新光 青岛海泰新光科技股份有限公司 二零二五年十月 声 明 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 本公司所有激励对象承诺，公司因信息披露文件中有虚假记载、误导性陈述 或者重大遗漏，导致不符合授予权益或权益归属安排的，激励对象应当自相关信 息披露文件被确认存在虚假记载、误导性陈述或者重大遗漏后，将由本激励计划 所获得的全部利益返还公司。 1 特别提示 一、本激励计划系依据《中华人民共和国公司法》《中华人民共和国证券法》《上 海证券交易所科创板股票上市规则》《上市公司股权激励管理办法》《科创板上 市公司持续监管办法（试行）》《科创板上市公司自律监管指南第 4 号——股权 激励信息披露》等其他有关法律法规、规范性文件，以及《青岛海泰新光科技股 份有限公司章程》制订。 二、本激励计划采取的激励工具为限制性股票（第二类限制性股票）。股票来源 为青岛海泰新光科技股份有限公司（以下简称"公司"或"本公司"）向激励对 象定向发行及/或自二级市场回购的公司 A 股普通股股票。 青岛海泰新光科技 ...

证券代码：688677 证券简称：海泰新光 公告编号：2025-061 青岛海泰新光科技股份有限公司 2025 年限制性股票激励计划（草案）摘要公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 股权激励方式：限制性股票（第二类限制性股票） 股份来源：公司从二级市场回购的本公司 A 股普通股股票和/或向激励 对象定向发行的本公司 A 股普通股股票 股权激励的权益总数及涉及的标的股票总数：青岛海泰新光科技股份有 限公司（以下简称"公司"）2025 年限制性股票激励计划（以下简称"本激励 计划"）拟向激励对象授予 100 万股限制性股票，约占本激励计划草案公告日公 司股本总额 11,987.7 万股的 0.8342%。其中，首次授予 80 万股，约占本激励计 划草案公告时公司股本总额的 0.6674%，约占本次授予权益总额的 80%；预留 20 万股，约占本激励计划草案公告时公司股本总额的 0.1668%，约占本次授予权益 总额的 20%。 一、股权激励计划目的 为进一步激发企业创新创造活力，建立、健全公司长 ...

注：1、上述任何一名激励对象通过全部在有效期内的股权激励计划获授的本公司股票均未超过公司总股本 的 1%。公司全部在有效期内的股权激励计划所涉及的标的股票总数累计不超过本股权激励计划草案提交股 东会时公司股本总额的 20%。激励对象离职或因个人原因自愿放弃获授权益的，由董事会对授予数量作相 应调整，可以将激励对象放弃的权益份额调整到预留部分或在激励对象之间进行分配调整或直接调减。 2、本计划首次授予部分的激励对象不包括独立董事。 3、预留部分的激励对象由本激励计划经股东会审议通过后 12 个月内确定，经董事会提出、薪酬与考核委 员会发表明确意见、独立财务顾问及律师发表专业意见并出具独立财务顾问报告、法律意见书后，公司在 指定网站按要求及时准确披露当次激励对象相关信息。 青岛海泰新光科技股份有限公司 2025 年限制性股票激励计划激励对象名单 | 姓名 | 国籍 | 姓名 | 国籍 | | --- | --- | --- | --- | | C***J*** | 美国 | C***N*** | 美国 | | Z***X*** | 美国 | W***P*** | 美国 | | D***C*** | 美国 | C* ...

競天公誠律師事務所 JINGTIAN & GONGCHENG 浙江省杭州市上城区华润大厦 A 座 3001 室 邮编:310017 Room 01, 30/F, Area A. China Resources Tower, No.1366, Oianiiang Road, Hangzhou, China T: (86-571) 8992 6500 F: (86-571) 8992 650 北京竞天公诚 关于青岛海泰新: 2025 年限制性股票激 法律意见书 致:青岛海泰新光科技股份有限公司 北京竞天公诚(杭州)律师事务所(以下简称"本所")接受青岛海泰新光 科技股份有限公司(以下简称"海泰新光"或"公司"）的委托,作为公司 2025 年限制性股票激励计划(以下简称"本激励计划"或"本计划")的专项法律顾 问. 就海泰新光实行本激励计划所涉及的相关事宜出具本法律意见书。 本所律师声明事项: 1、本法律意见书系依据《中华人民共和国公司法》（以下简称"《公司 法》"）、《中华人民共和国证券法》（以下简称"《证券法》"）、中国 证券监督管理委员会（以下简称"中国证监会"）《上市公司股权激励管理 办法(2025修正)》 ...

国泰海通证券股份有限公司 二零二五年十月 | 第一章 | 释义 1 | | | --- | --- | --- | | 第二章 | 声明 2 | | | 第三章 | 基本假设 | 3 | | 第四章 | 本次限制性股票激励计划的主要内容 | 4 | | 第五章 | 独立财务顾问意见 | 13 | | 第六章 | 备查文件及咨询方式 | 19 | 独立财务顾问报告 关于 青岛海泰新光科技股份有限公司 2025 年限制性股票激励计划（草案） 之 独立财务顾问报告 独立财务顾问： 第一章 释义 | 如无特殊说明，以下词语在本独立财务顾问报告中具有如下含义： | | --- | | 公司、上市公司、 | 指 | 青岛海泰新光科技股份有限公司 | | --- | --- | --- | | 海泰新光 | | | | 美国奥美克 | 指 | 海泰新光孙公司，OMEC Medical (NV) Inc. | | 泰国奥美克 | 指 | 海泰新光孙公司，OMEC THAI Co., Ltd. | | 限制性股票激励计划、 | 指 | 青岛海泰新光科技股份有限公司 年限制性股票激励计划 2025 | | 本激励计划、本计划 | ...

Company Performance - Haitai Xinguang reported a revenue of approximately 448 million yuan for the first three quarters of 2025, representing a year-on-year increase of 40.47% [1] - The net profit attributable to shareholders was approximately 136 million yuan, reflecting a year-on-year growth of 40.03% [1] - Basic earnings per share reached 1.14 yuan, which is a year-on-year increase of 40.74% [1] Market Valuation - As of the report date, Haitai Xinguang's market capitalization stood at 5.8 billion yuan [2]

Group 1 - The core point of the news is that Haitai Xinguang has announced an incentive plan involving the grant of 1 million restricted stocks to 15 employees, representing approximately 0.8342% of the company's total share capital [1] - The grant price for the restricted stocks is set at 25 yuan per share, with a maximum validity period of 60 months from the date of grant [1] - In terms of revenue composition for the year 2024, medical device manufacturing accounts for 77.94%, optical medical industry for 21.55%, and other businesses for 0.51% [1] Group 2 - As of the latest update, Haitai Xinguang has a market capitalization of 5.8 billion yuan [2]